Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

dapagliflozin-sAXagliptin

dapagliflozin-sAXagliptin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Qtern TABLET, ORAL 10 mg-5 mg    
Comments:

Qtern medication guide

Ordered Formulation Therapeutic Interchange

dapagliflozin-sAXagliptin (Qtern)

  • 10 mg-5 mg tablet oral

dapagliflozin (Farxiga) AND sAXagliptin (Onglyza)

  • ONE 10 mg dapagliflozin tablet oral PLUS ONE sAXagliptin 5 mg tablet oral

Non-formulary. To be given as separate components.

Reviewed: 23 May 2017 (Qtern)

Last updated: Dec. 26, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved